plumbagin has been researched along with Lung Neoplasms in 11 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 8 (72.73) | 24.3611 |
2020's | 3 (27.27) | 2.80 |
Authors | Studies |
---|---|
Im, E; Kang, CG; Lee, EO; Lee, HJ | 1 |
Guo, J; Ma, K; Ma, Q; Sun, S; Xu, J; Xu, W; Yang, R; Yang, Y; Zhang, J; Zhang, Y | 1 |
Basu, B; Checker, R; Pal, D; Patwardhan, RS; Sandur, SK; Sharma, D | 1 |
Biswal, BK; Rengasamy, KRR; Tripathi, SK | 1 |
Fan, XX; Huang, JM; Jiang, ZB; Leung, EL; Ma, YP; Wang, QQ; Wang, W; Wang, XR; Wu, QB; Xie, C; Xie, YJ; Xu, C; Yan, PY; Yao, XJ; Zhang, YZ | 1 |
Li, KY; Liu, G; Shao, Y; Xu, YY; Yu, T; Zhang, YY | 1 |
Liu, LX; Shen, H; Shu, YQ; Xu, TP | 1 |
Itharat, A; Pawa, KK; Rattarom, R; Ruangnoo, S; Sakpakdeejaroen, I; Tappayutpijam, P | 1 |
Chow, K; Duan, W; He, SM; He, ZX; Huang, GH; Li, M; Li, YC; Liu, A; Liu, JP; Pang, JX; Qiu, JX; Yang, T; Yang, Y; Zhang, X; Zhou, Q; Zhou, SF; Zhou, ZW | 1 |
Hansakul, P; Itharat, A; Rattarom, R; Sakpakdeejaroen, I | 1 |
Chang, WT; Chao, CH; Chiang, TA; Huang, GY; Lee, YC; Shieh, JM; Shih, YW; Shih, YX | 1 |
11 other study(ies) available for plumbagin and Lung Neoplasms
Article | Year |
---|---|
Plumbagin reduces osteopontin-induced invasion through inhibiting the Rho-associated kinase signaling pathway in A549 cells and suppresses osteopontin-induced lung metastasis in BalB/c mice.
Topics: A549 Cells; Animals; Antineoplastic Agents, Phytogenic; Carcinoma, Non-Small-Cell Lung; Cell Movement; Humans; Lung; Lung Neoplasms; Male; Mice, Inbred BALB C; Mice, Nude; Naphthoquinones; Neoplasm Invasiveness; Osteopontin; Plumbaginaceae; Protein Kinase Inhibitors; rho-Associated Kinases; Signal Transduction | 2017 |
Plumbagin reduction by thioredoxin reductase 1 possesses synergy effects with GLUT1 inhibitor on KEAP1-mutant NSCLC cells.
Topics: Animals; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Survival; Glucose Transporter Type 1; Humans; Kelch-Like ECH-Associated Protein 1; Lung Neoplasms; Naphthoquinones; NF-E2-Related Factor 2; Pyrazoles; Quinolines; Rats; Reactive Oxygen Species; Selenocysteine; Thioredoxin Reductase 1 | 2022 |
Modulation of Caspase-3 activity using a redox active vitamin K3 analogue, plumbagin, as a novel strategy for radioprotection.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Caspase 3; Cell Proliferation; Gamma Rays; Gene Expression Regulation, Enzymologic; Humans; Lung Neoplasms; Lymphocytes; Mice; Naphthoquinones; Oxidation-Reduction; Phosphorylation; Radiation-Protective Agents | 2019 |
Plumbagin engenders apoptosis in lung cancer cells via caspase-9 activation and targeting mitochondrial-mediated ROS induction.
Topics: A549 Cells; Antineoplastic Agents, Phytogenic; Apoptosis; Caspase 9; Cell Movement; Cell Proliferation; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Lung Neoplasms; Membrane Potential, Mitochondrial; Mitochondria; Molecular Structure; Naphthoquinones; Reactive Oxygen Species; Structure-Activity Relationship; Tumor Cells, Cultured | 2020 |
Plumbagin suppresses non-small cell lung cancer progression through downregulating ARF1 and by elevating CD8
Topics: ADP-Ribosylation Factor 1; Animals; Antineoplastic Agents, Phytogenic; Carcinoma, Non-Small-Cell Lung; CD8-Positive T-Lymphocytes; Cell Line, Tumor; Down-Regulation; Female; Lung Neoplasms; Lymphocyte Activation; Mice, Nude; Naphthoquinones; Neoplasm Transplantation | 2021 |
Plumbagin suppresses the human large cell lung cancer cell lines by inhibiting IL-6/STAT3 signaling in vitro.
Topics: Antineoplastic Agents; Carcinoma, Large Cell; Cell Line, Tumor; Cell Movement; Cell Proliferation; Humans; Interleukin-6; Lung Neoplasms; Naphthoquinones; Phosphorylation; Signal Transduction; STAT3 Transcription Factor | 2018 |
Plumbagin from Plumbago Zeylanica L induces apoptosis in human non-small cell lung cancer cell lines through NF- κB inactivation.
Topics: Apoptosis; Blotting, Western; Carcinoma, Non-Small-Cell Lung; Cell Proliferation; Electrophoretic Mobility Shift Assay; Humans; Luciferases; Lung Neoplasms; Naphthoquinones; NF-kappa B; Plumbaginaceae; Protein Transport; Superoxides; Tumor Cells, Cultured | 2013 |
In vitro cytotoxic activity of Benjakul herbal preparation and its active compounds against human lung, cervical and liver cancer cells.
Topics: Alkaloids; Benzodioxoles; Catechols; Cell Line, Tumor; Fatty Alcohols; Female; Humans; Liver Neoplasms; Lung Neoplasms; Medicine, East Asian Traditional; Naphthoquinones; Phytotherapy; Piper; Piperidines; Plant Extracts; Plants, Medicinal; Plumbaginaceae; Polyunsaturated Alkamides; Thailand; Uterine Cervical Neoplasms; Zingiber officinale | 2012 |
Plumbagin induces apoptotic and autophagic cell death through inhibition of the PI3K/Akt/mTOR pathway in human non-small cell lung cancer cells.
Topics: Apoptosis; Autophagy; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Humans; Lung Neoplasms; MAP Kinase Signaling System; Naphthoquinones; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Proto-Oncogene Proteins c-akt; TOR Serine-Threonine Kinases | 2014 |
Cytotoxic activity against small cell lung cancer cell line and chromatographic fingerprinting of six isolated compounds from the ethanolic extract of Benjakul.
Topics: Alkaloids; Benzodioxoles; Catechols; Cell Line, Tumor; Chromatography, High Pressure Liquid; Drug Screening Assays, Antitumor; Ethanol; Fatty Alcohols; Humans; Lung Neoplasms; Medicine, Traditional; Naphthoquinones; Piper; Piperidines; Plant Extracts; Plumbaginaceae; Polyunsaturated Alkamides; Small Cell Lung Carcinoma; Thailand; Zingiber officinale | 2014 |
Plumbagin inhibits TPA-induced MMP-2 and u-PA expressions by reducing binding activities of NF-kappaB and AP-1 via ERK signaling pathway in A549 human lung cancer cells.
Topics: Cell Line, Tumor; Humans; Lung Neoplasms; Matrix Metalloproteinase 2; Matrix Metalloproteinase Inhibitors; Mitogen-Activated Protein Kinase 3; Naphthoquinones; NF-kappa B; Phosphorylation; Signal Transduction; Tetradecanoylphorbol Acetate; Transcription Factor AP-1; Urokinase-Type Plasminogen Activator | 2010 |